PMID- 28851194
OWN - NLM
STAT- MEDLINE
DCOM- 20190617
LR  - 20190617
IS  - 0412-4081 (Print)
IS  - 0412-4081 (Linking)
VI  - 53
IP  - 8
DP  - 2017 Aug 11
TI  - [Pay attention to the application of the international intraocular retinoblastoma 
      classification and sequential multiple modality treatment].
PG  - 561-565
LID - 10.3760/cma.j.issn.0412-4081.2017.08.001 [doi]
AB  - Retinoblastoma (RB) is the most common intraocular malignancy in childhood. It 
      may seriously affect vision, and even threaten the life. The early diagnosis rate 
      of RB in China remains low, and the majority of patients are at late phase with 
      high rates of enucleation and mortality. The International Intraocular 
      Retinoblastoma Classification and TNM staging system are guidances for 
      therapeutic choices and bases for prognosis evaluation. Based on the sequential 
      multi-method treatment modality, chemotherapy combined with local therapy is the 
      mainstream in dealing with RB, which may maximize the results of eye saving and 
      even vision retaining. New therapeutic techniques including supra-selective 
      ophthalmic artery interventional chemotherapy and intravitreal chemotherapy can 
      further improve the efficacy of treatment, especially the eye salvage rate. The 
      overall level of RB treatment should be improved by promoting the international 
      staging, new therapeutic techniques, and the sequential multiple modality 
      treatment. (Chin J Ophthalmol, 2017, 53: 561-565).
FAU - Fan, X Q
AU  - Fan XQ
AD  - Department of Opthalmology, Ninth People's Hospital, Shanghai Jiao Tong 
      University School of Medicine, Shanghai 200011, China.
LA  - chi
PT  - Journal Article
PL  - China
TA  - Zhonghua Yan Ke Za Zhi
JT  - [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
JID - 16210540R
SB  - IM
MH  - Antineoplastic Combined Chemotherapy Protocols
MH  - Child
MH  - China
MH  - Combined Modality Therapy
MH  - Eye Enucleation
MH  - Humans
MH  - Infant
MH  - *Retinal Neoplasms/diagnosis/therapy
MH  - *Retinoblastoma/diagnosis/therapy
MH  - Retrospective Studies
OTO - NOTNLM
OT  - Antineoplastic protocols
OT  - Combined modality therapy
OT  - Infusions, intra-arterial
OT  - International classification of diseases
OT  - Intravitreal injections
OT  - Neoplasm staging
OT  - Retinoblastoma
EDAT- 2017/08/31 06:00
MHDA- 2019/06/18 06:00
CRDT- 2017/08/31 06:00
PHST- 2017/08/31 06:00 [entrez]
PHST- 2017/08/31 06:00 [pubmed]
PHST- 2019/06/18 06:00 [medline]
AID - 10.3760/cma.j.issn.0412-4081.2017.08.001 [doi]
PST - ppublish
SO  - Zhonghua Yan Ke Za Zhi. 2017 Aug 11;53(8):561-565. doi: 
      10.3760/cma.j.issn.0412-4081.2017.08.001.